Most of India's leading pharmaceutical companies are stuck in one such chaotic logjam. Like its peers, Lupin, the USD2.34 billion Mumbai-based drug ...
Read more: Pharma's new world dares Lupin's Vinita Gupta once again. And she is set to fight it out.